CSS
BMY icon

Cubist Systematic Strategies’s Bristol-Myers Squibb BMY Stock Holding History

Cubist Systematic Strategies’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$695K Sell
15,400
-34,500
-69% -$1.61M ﹤0.01% 2118
2025
Q2 		$2.31M Sell
49,900
-38,800
-44% -$1.9M 0.01% 1491
2025
Q1 		$5.41M Sell
88,700
-23,800
-21% -$1.39M 0.03% 839
2024
Q4 		$6.36M Sell
112,500
-97,600
-46% -$5.45M 0.04% 695
2024
Q3 		$10.9M Sell
210,100
-42,900
-17% -$2.01M 0.07% 419
2024
Q2 		$10.5M Buy
253,000
+168,000
+198% +$7.52M 0.07% 382
2024
Q1 		$4.61M Sell
85,000
-309,900
-78% -$15.8M 0.03% 1010
2023
Q4 		$20.3M Buy
394,900
+2,200
+0.6% +$115K 0.13% 156
2023
Q3 		$22.8M Buy
392,700
+142,200
+57% +$8.71M 0.17% 101
2023
Q2 		$16M Buy
250,500
+22,400
+10% +$1.5M 0.11% 193
2023
Q1 		$15.8M Buy
228,100
+27,700
+14% +$1.95M 0.1% 233
2022
Q4 		$14.4M Sell
200,400
-138,100
-41% -$10.4M 0.08% 295
2022
Q3 		$24.1M Sell
338,500
-12,200
-3% -$885K 0.14% 108
2022
Q2 		$27M Buy
+350,700
New +$26.7M 0.17% 59

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cubist Systematic Strategies's BMY Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Bristol-Myers Squibb (BMY) in Q3 2025: 377,758 shares worth $17M. The stake represents 0.08% of the portfolio and ranks #329 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in BMY as recently as Q4 2024.

Cubist Systematic Strategies first reported a position in BMY in Q2 2014 and has held it in 42 quarters since. The position peaked at $50.7M in Q2 2023. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Cubist Systematic Strategies held 377,758 shares of Bristol-Myers Squibb worth $17M as of Q3 2025.
  • Bristol-Myers Squibb was a new Cubist Systematic Strategies position in Q3 2025.
  • Bristol-Myers Squibb made up 0.08% of Cubist Systematic Strategies's portfolio in Q3 2025, its #329 holding.
  • Cubist Systematic Strategies first reported a position in Bristol-Myers Squibb in Q2 2014 and has held it in 42 quarters since.
  • Cubist Systematic Strategies's Bristol-Myers Squibb position peaked at $50.7M in Q2 2023.
  • 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.